Table 2.
Frequency of different clinical manifestations in children with confirmed SARS-CoV-2 infection versus children with unconfirmed suspected infection.
| Presentation | SARS-CoV-2 infection, n = 33 |
No infection, n = 93 |
P | ||
|---|---|---|---|---|---|
| Sign or symptom | Frequency | Percentage | Frequency | Percentage | |
| Fever | |||||
| At onset of symptoms | 10 | 30.3 | 36 | 38.7 | .389 |
| During the course of disease | 18 | 54.5 | 75 | 80.7 | .008 |
| Headache | |||||
| At onset of symptoms | 0 | 0.0 | 3 | 3.2 | NC |
| During the course of disease | 14 | 42.4 | 18 | 19.4 | .009 |
| Cough | |||||
| At onset of symptoms | 2 | 6.1 | 2 | 2.2 | NC |
| During the course of disease | 11 | 33.3 | 39 | 41.9 | .416 |
| Asthenia | |||||
| At onset of symptoms | 1 | 3.0 | 1 | 1.1 | NC |
| During the course of disease | 11 | 33.3 | 30 | 32.3 | 1.000 |
| Diarrhoea | |||||
| At onset of symptoms | 0 | 0.0 | 11 | 11.8 | NC |
| During the course of disease | 9 | 27.3 | 19 | 20.4 | .467 |
| Myalgia | |||||
| At onset of symptoms | 0 | 0.0 | 2 | 2.2 | NC |
| During the course of disease | 9 | 27.3 | 20 | 21.5 | .482 |
| Breathing difficulty | |||||
| At onset of symptoms | 4 | 12.1 | 3 | 3.2 | NC |
| During the course of disease | 7 | 21.2 | 28 | 30.1 | .370 |
| Cutaneous manifestations | |||||
| At onset of symptoms | 0 | 0.0 | 1 | 1.1 | NC |
| During the course of disease | 7 | 21.2 | 16 | 17.2 | .607 |
| Odynophagia | |||||
| At onset of symptoms | 2 | 6.1 | 6 | 6.5 | NC |
| During the course of disease | 6 | 18.2 | 27 | 29 | .257 |
| Chills | |||||
| At onset of symptoms | 3 | 9.1 | 19 | 20.4 | NC |
| During the course of disease | 6 | 18.2 | 21 | 22.6 | .805 |
| Wheezing | |||||
| At onset of symptoms | 1 | 3.0 | 0 | 0.0 | NC |
| During the course of disease | 6 | 18.2 | 30 | 32.3 | .170 |
| Anosmia/hyposmia | |||||
| At onset of symptoms | 0 | 0.0 | 1 | 1.1 | NC |
| During the course of disease | 5 | 15.2 | 3 | 3.2 | .029 |
| Rhinorrhoea | |||||
| At onset of symptoms | 4 | 12.1 | 1 | 1.1 | NC |
| During the course of disease | 4 | 12.1 | 11 | 11.8 | 1.000 |
| Dysgeusia | |||||
| At onset of symptoms | 1 | 3.0 | 0 | 0.0 | NC |
| During the course of disease | 4 | 12.1 | 6 | 6.5 | .288 |
| Abdominal pain | |||||
| At onset of symptoms | 0 | 0.0 | 5 | 5.4 | NC |
| During the course of disease | 2 | 6.1 | 25 | 26.9 | .012 |
| Vomiting | |||||
| At onset of symptoms | 0 | 0.0 | 1 | 1.1 | NC |
| During the course of disease | 0 | 0.0 | 16 | 17.2 | .011 |
Ordered by frequency in children with SARS-CoV-2 infection.
NC: not calculated due to the sample size.